Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11447479 Compounds active towards nuclear receptors

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114474790

Date of Patent

September 20, 2022

Patent Application Number

171261700

Date Filed

December 18, 2020

Patent Citations

‌

US Patent 10683393 Methods of solid freeform fabrication

‌

US Patent 10689383 Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

Patent Primary Examiner

CPC Code

Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11447479 Compounds active towards nuclear receptors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API